Novel Role of Fumarate Metabolism in Dahl-salt Sensitive Hypertension
Overview
Authors
Affiliations
In a previous proteomic study, we found dramatic differences in fumarase in the kidney between Dahl salt-sensitive rats and salt-insensitive consomic SS-13(BN) rats. Fumarase catalyzes the conversion between fumarate and l-malate in the tricarboxylic acid cycle. Little is known about the pathophysiological significance of fumarate metabolism in cardiovascular and renal functions, including salt-induced hypertension. The fumarase gene is located on the chromosome substituted in the SS-13(BN) rat. Sequencing of fumarase cDNA indicated the presence of lysine at amino acid position 481 in Dahl salt-sensitive rats and glutamic acid in Brown Norway and SS-13(BN) rats. Total fumarase activity was significantly lower in the kidneys of Dahl salt-sensitive rats compared with SS-13(BN) rats, despite an apparent compensatory increase in fumarase abundance in Dahl salt-sensitive rats. Intravenous infusion of a fumarate precursor in SS-13(BN) rats resulted in a fumarate excess in the renal medulla comparable to that seen in Dahl salt-sensitive rats. The infusion significantly exacerbated salt-induced hypertension in SS-13(BN) rats (140+/-3 vs125+/-2 mm Hg in vehicle control at day 5 on a 4% NaCl diet; P<0.05). In addition, the fumarate infusion increased renal medullary tissue levels of H2O2. Treatment of cultured human renal epithelial cells with the fumarate precursor also increased cellular levels of H2O2. These data suggest a novel role for fumarate metabolism in salt-induced hypertension and renal medullary oxidative stress.
Deletion of altered transcriptomic and metabolomic profiles of Dahl salt-sensitive rats.
Xu B, Dissanayake L, Levchenko V, Zietara A, Kravtsova O, Staruschenko A iScience. 2024; 27(10):110901.
PMID: 39328933 PMC: 11424968. DOI: 10.1016/j.isci.2024.110901.
Renal Epithelial Mitochondria: Implications for Hypertensive Kidney Disease.
Stadler K, Ilatovskaya D Compr Physiol. 2023; 14(1):5225-5242.
PMID: 38158371 PMC: 11194858. DOI: 10.1002/cphy.c220033.
Edosuyi O, Igbe I, Oyekan A Eur J Pharmacol. 2023; 961:176186.
PMID: 37944846 PMC: 10843741. DOI: 10.1016/j.ejphar.2023.176186.
Edosuyi O, Adesuyi A, Choi M, Igbe I, Oyekan A Eur J Pharmacol. 2022; 938:175441.
PMID: 36463945 PMC: 9772084. DOI: 10.1016/j.ejphar.2022.175441.
Ou-Yang Y, Yuan M, Yang Z, Min Z, Jin Y, Tian Z Metabolites. 2022; 12(11).
PMID: 36355159 PMC: 9694938. DOI: 10.3390/metabo12111076.